Evidence map›Paper›PMID 9658088›Full record

ArticleJournal of virology1998

Brefeldin A inhibits cell-free, de novo synthesis of poliovirus.

A Cuconati, A Molla, E Wimmer

Abstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

A CuconatiDepartment of Molecular Genetics and Microbiology, School of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794, USA.
A Molla
E Wimmer

Funding

POLIOVIRUS--MOLECULAR BIOLOGY AND SURFACE STRUCTURER37AI015122 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI WIMMER, ECKARD · 1988 to 2007
$3.8M
NIAID NIH HHS 5R37AI15122NIAID NIH HHS R37 AI015122
6 · The paper itself

Abstract

Brefeldin A (BFA), an inhibitor of intracellular vesicle-dependent secretory transport, is a potent inhibitor of poliovirus RNA replication in infected cells. We have determined that the unknown mechanism of BFA inhibition of replication is reproduced in the cell-free poliovirus translation, replication, and encapsidation system. Furthermore, we provide evidence suggesting that the cellular mechanism targeted by BFA, the GTP-dependent synthesis of secretory transport vesicles, may be involved in viral RNA replication in the system via a soluble cellular GTP-binding and -hydrolyzing activity. This activity is related to the ARF (ADP-ribosylation factor) family of GTP-binding proteins. ARFs are required for the formation of several classes of secretory vesicles, and some family members are indirectly inactivated by BFA. Peptides that function as competitive inhibitors of ARF activity in cell-free transport systems also inhibit poliovirus RNA replication, and this inhibitory effect can be countered by the addition of exogenous ARF. We suggest that BFA inhibition of replication is diagnostic of a requirement for ARF activity in the cell-free system.

Indexed as

ADP-Ribosylation FactorsAnimalsAnti-Bacterial AgentsAntiviral AgentsBinding, CompetitiveBrefeldin ACell-Free SystemCyclopentanesGTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)HeLa CellsHumansMacrolidesMicePoliovirusVirus ReplicationADP-Ribosylation FactorsAnti-Bacterial AgentsAntiviral AgentsBrefeldin ACyclopentanesGTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)Macrolides

Identifiers

PMID9658088
PMCPMC109807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.